Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Margot W. Beukers"'
Autor:
Dirk-Jan van den Berg, Elizabeth C. M. de Lange, Pyry A. J. Välitalo, Margot W. Beukers, Johan G. C. van Hasselt, Walter Krauwinkel, An Vermeulen, Robin Hartman, Yumi Yamamoto, Meindert Danhof, Yin Cheong Wong, Dymphy Huntjens, Johannes H. Proost
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology
Drug development targeting the central nervous system (CNS) is challenging due to poor predictability of drug concentrations in various CNS compartments. We developed a generic physiologically based pharmacokinetic (PBPK) model for prediction of drug
Autor:
Yin Cheong Wong, Meindert Danhof, Hannu Kokki, Pyry A. J. Välitalo, Merja Kokki, An Vermeulen, Johannes H. Proost, Johan G. C. van Hasselt, Walter Krauwinkel, Yumi Yamamoto, Elizabeth C. M. de Lange, Margot W. Beukers, Dymphy Huntjens
Publikováno v:
European Journal of Pharmaceutical Sciences, 112, 168-179
European Journal of Pharmaceutical Sciences, 112, 168-179. ELSEVIER SCIENCE BV
European Journal of Pharmaceutical Sciences
European Journal of Pharmaceutical Sciences, 112, 168-179. ELSEVIER SCIENCE BV
European Journal of Pharmaceutical Sciences
Knowledge of drug concentration-time profiles at the central nervous system (CNS) target-site is critically important for rational development of CNS targeted drugs. Our aim was to translate a recently published comprehensive CNS physiologically-base
Autor:
Gerard J. P. van Westen, Margot W. Beukers, Miriam C. Peeters, Christa E. Müller, Lisanne E Wisse, Dong Guo, Adriaan P. IJzerman
Publikováno v:
The FASEB Journal. 25:632-643
The highly variable extracellular loops in G protein-coupled receptors (GPCRs) have been implicated in receptor activation, the mechanism of which is poorly understood. In a random mutagenesis screen on the human adenosine A(2B) receptor (A(2B)R) usi
Autor:
Judy Lin, John van Bruchem, Adriaan P. IJzerman, J. Robert Lane, Margot W. Beukers, Elisabeth Klaasse
Publikováno v:
Biochemical Pharmacology. 80:1180-1189
The adenosine A(1) receptor is a promising therapeutic target for neurological disorders such as cognition deficits and is involved in cardiovascular preconditioning. Classically adenosine receptor agonists were all derivatives of adenosine, and thou
Autor:
Kai Ye, Ad P. IJzerman, Margot W. Beukers, Jaap Brouwer, Clara C. Blad, Hans den Dulk, Qilan Li
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 320:637-645
The human adenosine A(2B) receptor belongs to class A G protein-coupled receptors (GPCRs). In our previous work, constitutively active mutant (CAM) human adenosine A(2B) receptors were identified from a random mutation bank. In the current study, thr
Publikováno v:
Medicinal Research Reviews. 26:667-698
Many selective and high affinity agonists and antagonists have been developed for the adenosine A1, A2A, and A3 receptors. Very recently such compounds have been identified for the adenosine A2B receptors. This review presents an overview of the stru
Autor:
Lisa C. W. Chang, Adriaan P. IJzerman, Johannes Brussee, Jacobien K. Von Frijtag Drabbe Künzel, Margot W. Beukers, Gijs Van Den Hout, Thea Mulder-Krieger, Ronald F. Spanjersberg
Publikováno v:
Journal of Medicinal Chemistry. 47:6529-6540
Adenosine receptor antagonists usually possess a bi- or tricyclic heteroaromatic structure at their core with varying substitution patterns to achieve selectivity and/or greater affinity. Taking into account molecular modeling results from a series o
Autor:
Gijs Van Den Hout, Johannes Brussee, Ronald F. Spanjersberg, Lisa C. W. Chang, Sophie F. Roerink, Adriaan P. IJzerman, Thea Mulder-Krieger, Jacobien K. Von Frijtag Drabbe Künzel, Margot W. Beukers
Publikováno v:
Journal of Medicinal Chemistry. 48:2045-2053
Adenosine receptor agonists are usually variations of the natural ligand, adenosine. The ribose moiety in the ligand has previously been shown to be of great importance for the agonistic effects of the compound. In this paper, we present a series of
Autor:
Margot W. Beukers, Jaap Brouwer, Clara C. Blad, Hans den Dulk, Joris van Oppenraaij, Patrick P. W. van der Hoorn, Adriaan P. IJzerman
Publikováno v:
Molecular Pharmacology. 65:702-710
To gain insight in spontaneous as well as agonist-induced activation of the human adenosine A2B receptor, we applied a random mutagenesis approach in yeast to create a large number of receptor mutants and selected mutants of interest with a robust sc
Autor:
Danielle F. Sleegers, Jacobien K. von Frijtag Drabbe Knzel, Miriam de Groote, Maarten de Zwart, Roel C. Vollinga, Margot W. Beukers, Ad P. IJzerman
Publikováno v:
Drug Development Research. 48:95-103
A series of novel and known 5-substituted 7-amino-2-(2-furyl)[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives were synthesized and tested for adenosine receptor antagonism in radioligand binding assays at all four adenosine receptor subtypes and for